The present document describes a soluble complex which comprises a hemoglobin cross-linked with an antioxidant enzyme, and acid-base and carbon dioxide transport enzyme. Cross-linking is enhancing in vivo circulation time of the soluble complex, and prevents harmful in vivo effects that could be sustained by an individual subjected to the individual free components of the soluble complex.